Overall survival benefit of Osimertinib and clinical value of upfront cranial local therapy in untreated EGFR‐mutant non‐small cell lung cancer with brain metastasis

Corresponding Author

Jianjiao Ni

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Correspondence

Jianjiao Ni, MD Department of Radiation Oncology, Fudan University Shanghai Cancer Center 270 Dong An Road, Shanghai, 200032 China Phone: +86-13761974092 Fax: +86-2164175242

Email: nijianjiao8@shca.org.cn

Zhengfei Zhu, MD Department of Radiation Oncology, Fudan University Shanghai Cancer Center 270 Dong An Road, Shanghai, 200032 China Phone: +86-18017312901 Fax: +86-2164175242

Email: fuscczzf@fudan.edu.cn

Search for more papers by this author

留言 (0)

沒有登入
gif